Health Condition 1: R52- Pain, unspecified
Conditions
Interventions
Intervention1: Dexmedetomidine Intravenous: Dexmedetomidine Intravenous 1 microgram per kg bolus in 100 ml normal saline over 10 minutes followed by infusion at the rate of 0.2 microgram per kg per ho
Sponsors
PACIFIC MEDICAL COLLEGE AND HOSPITAL UDAIPUR
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged 18 65 years of either sex diagnosed with oral cancer scheduled for surgery under general anesthesia. ASA physical status 1 and 2 Cooperative and able to provide informed consent
Exclusion criteria
Exclusion criteria: Not giving written and informed consent Pregnant and Lactating women Known allergy to study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess and compare the effectiveness of sedation achieved by Dexmedetomidine versus Midazolam using Ramsay sedation score. To assess and compare the time required for intubation in minutes. To assess and compare the ease of intubation. To assess Patient comfort during intubation. Timepoint: To assess and compare the time required for intubation in minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess & compare the hemodynamic parameters To assess the incidence of adverse effects if any. To evaluate the patient recall postoperatively. Timepoint: To assess & compare the hemodynamic parameters To assess the incidence of adverse effects if any To evaluate the patient recall postoperatively at baseline 1min 2min 5min 10min 15min 30min 45min 60min | — |
Countries
India
Contacts
Public ContactDr Vijay Kumar
Outcome results
None listed